What is the P/E ratio of AsiaMedic 2024?
The P/E ratio cannot be calculated for AsiaMedic at the moment.
Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news
Subscribe for $2 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news
Overview
Profile
AsiaMedic stock price, quote, forecast and news stock price, forecast, news, chart, split, dividend and analysis AsiaMedic ariva, AsiaMedic onvista, AsiaMedic finanzen.net, AsiaMedic aktienfinder, AsiaMedic marketscreener, AsiaMedic marketwatch, AsiaMedic bloomberg, AsiaMedic handelsblatt, AsiaMedic wiwo, AsiaMedic forum
505.SI
SG0505000059
Price
Price
0.01
Today +/-
+0
Today %
+0 %
Ticker505.SI
ISINSG0505000059
P
AsiaMedic stock price
%
Weekly
Details
Price
ⓘOverview
The Quote Chart provides detailed and dynamic insights into the AsiaMedic stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.
Intraday Feature
The intraday feature provides real-time data, allowing investors to view the AsiaMedic stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.
Total Return and Relative Price Change
View the total return of the AsiaMedic stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.
Interpretation and Investment
Utilize the comprehensive data presented in the Quote Chart to analyze AsiaMedic's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.
AsiaMedic Stock Price History
| Date | AsiaMedic Price |
|---|---|
| 9/4/2024 | 0.01 undefined |
| 9/3/2024 | 0.01 undefined |
| 9/2/2024 | 0.01 undefined |
| 8/30/2024 | 0.01 undefined |
| 8/29/2024 | 0.01 undefined |
| 8/28/2024 | 0.01 undefined |
| 8/27/2024 | 0.01 undefined |
| 8/26/2024 | 0.01 undefined |
| 8/23/2024 | 0.01 undefined |
| 8/21/2024 | 0.01 undefined |
| 8/19/2024 | 0.01 undefined |
| 8/16/2024 | 0.01 undefined |
| 8/15/2024 | 0.01 undefined |
| 8/14/2024 | 0.01 undefined |
| 8/13/2024 | 0.01 undefined |
| 8/12/2024 | 0.01 undefined |
| 8/8/2024 | 0.01 undefined |
AsiaMedic Revenue, EBIT, Net Income SG0505000059 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into AsiaMedic, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by AsiaMedic from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects AsiaMedic’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of AsiaMedic. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into AsiaMedic’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing AsiaMedic’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on AsiaMedic’s growth potential.
AsiaMedic Revenue, EBIT and net profit per share
| Date | AsiaMedic Revenue | AsiaMedic EBIT | AsiaMedic Net Income |
|---|---|---|---|
| 2023 | 23.6 M undefined | 884,240 undefined | 1.92 M undefined |
| 2022 | 18.88 M undefined | 961,720 undefined | 2.19 M undefined |
| 2021 | 18.26 M undefined | 1.77 M undefined | 715,030 undefined |
| 2020 | 15.28 M undefined | -2.1 M undefined | -4.3 M undefined |
| 2019 | 18.99 M undefined | -691,150 undefined | -588,230 undefined |
| 2018 | 18.83 M undefined | -2.64 M undefined | -4.77 M undefined |
| 2017 | 19.02 M undefined | -2.98 M undefined | -4.23 M undefined |
| 2016 | 20.57 M undefined | -1.71 M undefined | -1.63 M undefined |
| 2015 | 20.2 M undefined | 307,780 undefined | -1.78 M undefined |
| 2014 | 18.79 M undefined | 384,600 undefined | 669,910 undefined |
| 2013 | 14.68 M undefined | -440,000 undefined | 50,000 undefined |
| 2012 | 11.89 M undefined | -150,000 undefined | 40,000 undefined |
| 2011 | 10.45 M undefined | -580,000 undefined | -810,000 undefined |
| 2010 | 10.66 M undefined | -80,000 undefined | 160,000 undefined |
| 2009 | 11.34 M undefined | 720,000 undefined | 780,000 undefined |
| 2008 | 12.26 M undefined | 1.32 M undefined | 1.33 M undefined |
| 2007 | 11.58 M undefined | 1.11 M undefined | 1.15 M undefined |
| 2006 | 10.78 M undefined | 380,000 undefined | 130,000 undefined |
| 2005 | 11.63 M undefined | 1.6 M undefined | 760,000 undefined |
| 2004 | 10.16 M undefined | 1.65 M undefined | 1.63 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 10.16 M SGD | 1.65 M SGD | 1.63 M SGD |
| 2005 | 11.63 M SGD | 1.6 M SGD | 760,000 SGD |
| 2006 | 10.78 M SGD | 380,000 SGD | 130,000 SGD |
| 2007 | 11.58 M SGD | 1.11 M SGD | 1.15 M SGD |
| 2008 | 12.26 M SGD | 1.32 M SGD | 1.33 M SGD |
| 2009 | 11.34 M SGD | 720,000 SGD | 780,000 SGD |
| 2010 | 10.66 M SGD | -80,000 SGD | 160,000 SGD |
| 2011 | 10.45 M SGD | -580,000 SGD | -810,000 SGD |
| 2012 | 11.89 M SGD | -150,000 SGD | 40,000 SGD |
| 2013 | 14.68 M SGD | -440,000 SGD | 50,000 SGD |
| 2014 | 18.79 M SGD | 384,600 SGD | 669,910 SGD |
| 2015 | 20.2 M SGD | 307,780 SGD | -1.78 M SGD |
| 2016 | 20.57 M SGD | -1.71 M SGD | -1.63 M SGD |
| 2017 | 19.02 M SGD | -2.98 M SGD | -4.23 M SGD |
| 2018 | 18.83 M SGD | -2.64 M SGD | -4.77 M SGD |
| 2019 | 18.99 M SGD | -691,150 SGD | -588,230 SGD |
| 2020 | 15.28 M SGD | -2.1 M SGD | -4.3 M SGD |
| 2021 | 18.26 M SGD | 1.77 M SGD | 715,030 SGD |
| 2022 | 18.88 M SGD | 961,720 SGD | 2.19 M SGD |
| 2023 | 23.6 M SGD | 884,240 SGD | 1.92 M SGD |
AsiaMedic Income Statement, Balance Sheet, Cash Flow Statement
Simple
Expanded
Income Statement
Balance Sheet
Cashflow
| 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 4 | 5 | 10 | 11 | 10 | 11 | 12 | 11 | 10 | 10 | 11 | 14 | 18 | 20 | 20 | 19 | 18 | 18 | 15 | 18 | 18 | 23 |
| - | -20.00 | 25.00 | 100.00 | 10.00 | -9.09 | 10.00 | 9.09 | -8.33 | -9.09 | - | 10.00 | 27.27 | 28.57 | 11.11 | - | -5.00 | -5.26 | - | -16.67 | 20.00 | - | 27.78 |
| 100.00 | 100.00 | 80.00 | 90.00 | 90.91 | 90.00 | 90.91 | 91.67 | 90.91 | 90.00 | 90.00 | 90.91 | 92.86 | 88.89 | 85.00 | 90.00 | 84.21 | 88.89 | 94.44 | 93.33 | 88.89 | 94.44 | 91.30 |
| 5 | 4 | 4 | 9 | 10 | 9 | 10 | 11 | 10 | 9 | 9 | 10 | 13 | 16 | 17 | 18 | 16 | 16 | 17 | 14 | 16 | 17 | 21 |
| -1,000 | -1,000 | -1,000 | 1,000 | 1,000 | 0 | 1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,000 | -2,000 | -2,000 | 0 | -2,000 | 1,000 | 0 | 0 |
| -20.00 | -25.00 | -20.00 | 10.00 | 9.09 | - | 9.09 | 8.33 | - | - | - | - | - | - | - | -5.00 | -10.53 | -11.11 | - | -13.33 | 5.56 | - | - |
| -3 | -1 | -1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -4 | -4 | 0 | -4 | 0 | 2 | 1 |
| - | -66.67 | - | -200.00 | - | - | - | - | - | - | - | - | - | - | - | - | 300.00 | - | - | - | - | - | -50.00 |
| 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.41 | 0.42 | 0.42 | 0.42 | 1.09 | 1.12 | 1.12 | 1.13 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Details
Keystats
ⓘRevenue and Growth
The AsiaMedic Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the AsiaMedic is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
AsiaMedic stock margins SG0505000059 ·
The AsiaMedic margin analysis displays the gross margin, EBIT margin, as well as the profit margin of AsiaMedic. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for AsiaMedic.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the AsiaMedic's sales revenue. A higher gross margin percentage indicates that the AsiaMedic retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the AsiaMedic's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the AsiaMedic's total revenue generated. When comparing the revenue margin year over year, investors can gauge the AsiaMedic's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the AsiaMedic. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the AsiaMedic's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
AsiaMedic Margin History
| AsiaMedic Gross margin | AsiaMedic Profit margin | AsiaMedic EBIT margin | AsiaMedic Profit margin |
|---|---|---|---|
| 2023 | 92.92 % | 3.75 % | 8.14 % |
| 2022 | 92.09 % | 5.09 % | 11.58 % |
| 2021 | 92.75 % | 9.69 % | 3.92 % |
| 2020 | 91.66 % | -13.73 % | -28.11 % |
| 2019 | 91.14 % | -3.64 % | -3.1 % |
| 2018 | 89.45 % | -14.03 % | -25.36 % |
| 2017 | 88.9 % | -15.69 % | -22.23 % |
| 2016 | 88.91 % | -8.31 % | -7.92 % |
| 2015 | 88.54 % | 1.52 % | -8.81 % |
| 2014 | 88.82 % | 2.05 % | 3.56 % |
| 2013 | 90.33 % | -3 % | 0.34 % |
| 2012 | 92.01 % | -1.26 % | 0.34 % |
| 2011 | 91.48 % | -5.55 % | -7.75 % |
| 2010 | 91.65 % | -0.75 % | 1.5 % |
| 2009 | 91.36 % | 6.35 % | 6.88 % |
| 2008 | 91.84 % | 10.77 % | 10.85 % |
| 2007 | 91.88 % | 9.59 % | 9.93 % |
| 2006 | 91.56 % | 3.53 % | 1.21 % |
| 2005 | 93.9 % | 13.76 % | 6.53 % |
| 2004 | 93.7 % | 16.24 % | 16.04 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 93.7 % | 16.24 % | 16.04 % |
| 2005 | 93.9 % | 13.76 % | 6.53 % |
| 2006 | 91.56 % | 3.53 % | 1.21 % |
| 2007 | 91.88 % | 9.59 % | 9.93 % |
| 2008 | 91.84 % | 10.77 % | 10.85 % |
| 2009 | 91.36 % | 6.35 % | 6.88 % |
| 2010 | 91.65 % | -0.75 % | 1.5 % |
| 2011 | 91.48 % | -5.55 % | -7.75 % |
| 2012 | 92.01 % | -1.26 % | 0.34 % |
| 2013 | 90.33 % | -3 % | 0.34 % |
| 2014 | 88.82 % | 2.05 % | 3.56 % |
| 2015 | 88.54 % | 1.52 % | -8.81 % |
| 2016 | 88.91 % | -8.31 % | -7.92 % |
| 2017 | 88.9 % | -15.69 % | -22.23 % |
| 2018 | 89.45 % | -14.03 % | -25.36 % |
| 2019 | 91.14 % | -3.64 % | -3.1 % |
| 2020 | 91.66 % | -13.73 % | -28.11 % |
| 2021 | 92.75 % | 9.69 % | 3.92 % |
| 2022 | 92.09 % | 5.09 % | 11.58 % |
| 2023 | 92.92 % | 3.75 % | 8.14 % |
AsiaMedic Stock Sales Revenue, EBIT, Earnings per Share SG0505000059 ·
The AsiaMedic earnings per share therefore indicates how much revenue AsiaMedic has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
3 years
5 years
10 years
25 Years
Max
Sales per Share
EBIT per share
Earnings per Share
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue AsiaMedic earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates AsiaMedic's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of AsiaMedic’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating AsiaMedic's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
AsiaMedic Revenue, EBIT and net profit per share
| Date | AsiaMedic Sales per Share | AsiaMedic EBIT per share | AsiaMedic Earnings per Share |
|---|---|---|---|
| 2023 | 0.02 undefined | 0 undefined | 0 undefined |
| 2022 | 0.02 undefined | 0 undefined | 0 undefined |
| 2021 | 0.02 undefined | 0 undefined | 0 undefined |
| 2020 | 0.01 undefined | -0 undefined | -0 undefined |
| 2019 | 0.05 undefined | -0 undefined | -0 undefined |
| 2018 | 0.05 undefined | -0.01 undefined | -0.01 undefined |
| 2017 | 0.05 undefined | -0.01 undefined | -0.01 undefined |
| 2016 | 0.05 undefined | -0 undefined | -0 undefined |
| 2015 | 0.06 undefined | 0 undefined | -0 undefined |
| 2014 | 0.05 undefined | 0 undefined | 0 undefined |
| 2013 | 0.04 undefined | -0 undefined | 0 undefined |
| 2012 | 0.03 undefined | -0 undefined | 0 undefined |
| 2011 | 0.03 undefined | -0 undefined | -0 undefined |
| 2010 | 0.03 undefined | -0 undefined | 0 undefined |
| 2009 | 0.03 undefined | 0 undefined | 0 undefined |
| 2008 | 0.03 undefined | 0 undefined | 0 undefined |
| 2007 | 0.03 undefined | 0 undefined | 0 undefined |
| 2006 | 0.03 undefined | 0 undefined | 0 undefined |
| 2005 | 0.04 undefined | 0.01 undefined | 0 undefined |
| 2004 | 0.03 undefined | 0.01 undefined | 0.01 undefined |
| Sales per Share | EBIT per share | Earnings per Share | |
|---|---|---|---|
| 2004 | 0.03 SGD | 0.01 SGD | 0.01 SGD |
| 2005 | 0.04 SGD | 0.01 SGD | 0 SGD |
| 2006 | 0.03 SGD | 0 SGD | 0 SGD |
| 2007 | 0.03 SGD | 0 SGD | 0 SGD |
| 2008 | 0.03 SGD | 0 SGD | 0 SGD |
| 2009 | 0.03 SGD | 0 SGD | 0 SGD |
| 2010 | 0.03 SGD | -0 SGD | 0 SGD |
| 2011 | 0.03 SGD | -0 SGD | -0 SGD |
| 2012 | 0.03 SGD | -0 SGD | 0 SGD |
| 2013 | 0.04 SGD | -0 SGD | 0 SGD |
| 2014 | 0.05 SGD | 0 SGD | 0 SGD |
| 2015 | 0.06 SGD | 0 SGD | -0 SGD |
| 2016 | 0.05 SGD | -0 SGD | -0 SGD |
| 2017 | 0.05 SGD | -0.01 SGD | -0.01 SGD |
| 2018 | 0.05 SGD | -0.01 SGD | -0.01 SGD |
| 2019 | 0.05 SGD | -0 SGD | -0 SGD |
| 2020 | 0.01 SGD | -0 SGD | -0 SGD |
| 2021 | 0.02 SGD | 0 SGD | 0 SGD |
| 2022 | 0.02 SGD | 0 SGD | 0 SGD |
| 2023 | 0.02 SGD | 0 SGD | 0 SGD |
AsiaMedic business model
AsiaMedic is one of the most popular companies on Eulerpool.com.
AsiaMedic Eulerpool Fair Value
Details
Fair Value
ⓘUnderstanding Fair Value
The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.
Income-Based Fair Value
This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.
Example 2022
Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)
Revenue-Based Fair Value
It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.
Example 2022
Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)
Dividend-Based Fair Value
This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.
Example 2022
Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)
Expectations and Forecasts
Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.
Comparative Analysis
Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.
AsiaMedic historical P/E ratio, EBIT, and P/S ratio.
AsiaMedic shares outstanding SG0505000059 ·
The number of shares was AsiaMedic in 2023 — This indicates how many shares 1.132 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue AsiaMedic earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates AsiaMedic's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of AsiaMedic’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating AsiaMedic's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 311.64 M Aktien |
| 2005 | 312.2 M Aktien |
| 2006 | 312.2 M Aktien |
| 2007 | 357.32 M Aktien |
| 2008 | 358.74 M Aktien |
| 2009 | 358.54 M Aktien |
| 2010 | 358.45 M Aktien |
| 2011 | 357.31 M Aktien |
| 2012 | 357.23 M Aktien |
| 2013 | 359.23 M Aktien |
| 2014 | 356.92 M Aktien |
| 2015 | 357.71 M Aktien |
| 2016 | 413.1 M Aktien |
| 2017 | 416.2 M Aktien |
| 2018 | 416.2 M Aktien |
| 2019 | 417.87 M Aktien |
| 2020 | 1.09 B Aktien |
| 2021 | 1.12 B Aktien |
| 2022 | 1.12 B Aktien |
| 2023 | 1.13 B Aktien |
AsiaMedic Stock splits
In AsiaMedic's history, there have been no stock splits.
AsiaMedic dividend history and estimates SG0505000059 ·
In 2023, AsiaMedic paid a dividend amounting to 0 SGD. Dividend means that AsiaMedic distributes a portion of its profits to its owners.
3 years
5 years
10 years
25 Years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for AsiaMedic provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify AsiaMedic’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating AsiaMedic's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
AsiaMedic Dividend History
| Date | AsiaMedic Dividend |
|---|---|
| 2010 | 0 undefined |
| 2009 | 0 undefined |
| 2006 | 0 undefined |
| 2005 | 0 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2004 | 0 SGD | 0 SGD |
| 2005 | 0 SGD | 0 SGD |
| 2006 | 0 SGD | 0 SGD |
| 2007 | 0 SGD | 0 SGD |
| 2008 | 0 SGD | 0 SGD |
| 2009 | 0 SGD | 0 SGD |
| 2010 | 0 SGD | 0 SGD |
| 2011 | 0 SGD | 0 SGD |
| 2012 | 0 SGD | 0 SGD |
| 2013 | 0 SGD | 0 SGD |
| 2014 | 0 SGD | 0 SGD |
| 2015 | 0 SGD | 0 SGD |
| 2016 | 0 SGD | 0 SGD |
| 2017 | 0 SGD | 0 SGD |
| 2018 | 0 SGD | 0 SGD |
| 2019 | 0 SGD | 0 SGD |
| 2020 | 0 SGD | 0 SGD |
| 2021 | 0 SGD | 0 SGD |
| 2022 | 0 SGD | 0 SGD |
| 2023 | 0 SGD | 0 SGD |
AsiaMedic does not pay out any dividends.
Unfortunately, there are currently no price targets and forecasts available for AsiaMedic.
AsiaMedic list of shareholders
% | Name | Stocks | Change | Date |
|---|---|---|---|---|
| 6.65 % | Dragon Glorious Ltd. | 76,813,516 | 76,813,516 | 11/21/2023 |
| 6.65 % | Capital Blaze Ltd. | 76,813,516 | 76,813,516 | 11/21/2023 |
| 31.05 % | Integral Lead Ltd. | 358,471,030 | 358,471,030 | 11/21/2023 |
| 0.72 % | Ang (Kim Joo Matthew) | 8,268,400 | 3,268,400 | 3/15/2023 |
| 0.67 % | Kong (Yuen Ho) | 7,790,000 | 1,690,000 | 3/15/2023 |
| 0.65 % | Lee (Chye Onn) | 7,499,000 | 499,000 | 3/15/2023 |
| 0.65 % | Listiawati | 7,454,000 | 0 | 3/15/2023 |
| 0.55 % | Ang (Hao Yao) | 6,388,800 | 6,388,800 | 3/15/2023 |
| 0.53 % | Loo (Tiong Kheng) | 6,099,900 | 0 | 3/15/2023 |
| 0.52 % | Tok (Boon Choo) | 6,008,200 | 6,008,200 | 3/15/2023 |
1
2
Most common questions regarding AsiaMedic
What is the P/S ratio of AsiaMedic 2024?
The P/S cannot be calculated for AsiaMedic currently.
What is the AlleAktien quality score of AsiaMedic?
The AlleAktien quality score for AsiaMedic is 1/10.
What is the revenue of AsiaMedic 2024?
The revenue cannot currently be calculated for AsiaMedic.
How high is the profit of AsiaMedic 2024?
The profit cannot currently be calculated for AsiaMedic.
What is the business model of AsiaMedic
No history available for AsiaMedic.
What is the AsiaMedic dividend?
AsiaMedic pays a dividend of 0 SGD distributed over payouts per year.
How often does AsiaMedic pay dividends?
The dividend cannot currently be calculated for AsiaMedic or the company does not pay out a dividend.
What is the AsiaMedic ISIN?
The ISIN of AsiaMedic is SG0505000059.
What is the AsiaMedic ticker?
The ticker of AsiaMedic is 505.SI.
How much dividend does AsiaMedic pay?
Over the past 12 months, AsiaMedic paid a dividend of 0 SGD . This corresponds to a dividend yield of about 5.12 %. For the coming 12 months, AsiaMedic is expected to pay a dividend of 0 SGD.
What is the dividend yield of AsiaMedic?
The current dividend yield of AsiaMedic is 5.12 %.
When does AsiaMedic pay dividends?
AsiaMedic pays a quarterly dividend. This is distributed in the months of June, June, May, May.
How secure is the dividend of AsiaMedic?
AsiaMedic paid dividends every year for the past 0 years.
What is the dividend of AsiaMedic?
For the upcoming 12 months, dividends amounting to 0 SGD are expected. This corresponds to a dividend yield of 0 %.
In which sector is AsiaMedic located?
AsiaMedic is assigned to the 'Health' sector.
Wann musste ich die Aktien von AsiaMedic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of AsiaMedic from 5/14/2010 amounting to 0.001 SGD, you needed to have the stock in your portfolio before the ex-date on 4/29/2010.
When did AsiaMedic pay the last dividend?
The last dividend was paid out on 5/14/2010.
What was the dividend of AsiaMedic in the year 2023?
In the year 2023, AsiaMedic distributed 0 SGD as dividends.
In which currency does AsiaMedic pay out the dividend?
The dividends of AsiaMedic are distributed in SGD.
AsiaMedic stock price, news, forecast, analysis
Sector
Health
Industry
Health Care Services
Number of shares
Employee
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website AsiaMedic
Country
Singapore 🇸🇬
Currency
SGD
Initial public offering
Feb 1, 1988
GOSIN
Global Open Securities Identification Number
Cusip
Y0330L123
Market capitalization
PEG
0
P/E
Forward P/E
0
P/S
Forward P/S
0
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC
Scalable Capital savings plan Nein
Trade Republic savings plan Nein
comdirect savings plan
Consorsbank savings plan Nein
ING savings plan Nein
AsiaMedic Peer Group
AsiaMedic Eulerpool News
AsiaMedic News
AsiaMedic FIGI
| AsiaMedic Ticker | AsiaMedic FIGI |
|---|---|
| AMAT:SP | BBG000BMQ946 |
All fundamentals about AsiaMedic
Our stock analysis for AsiaMedic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AsiaMedic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.